UNSPSC 51383304: Diclofenac

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51383304

Definition

This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H11Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 144O8QL0L1, chemically known as 2-((2,6-dichlorophenyl)amino)benzeneacetic acid but generally known as diclofenac, which bears US NIH Compound Identifier 3033. European Medicines Agency schedules Diclofenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07092MIG.

Read the full definition

The term DICLOFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules diclofenac in its Anatomical Therapeutic Chemical (ATC) Classification. DICLOFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diclofenac under HS 29224995 and SITC 51465. As of Q4 2014, DICLOFENAC remains the US FDA Preferred Term for this commodity. Diclofenac bears US NLM identifiers UMLS ID C0012091 and NCI Concept Code C28985.

SMILES: CLC1C(NC2C(CC(=O)O)CCCC2)C(CL)CCC1.

About UNSPSC 51383304

UNSPSC 51383304 Diclofenac is a Commodity code that nominally classifies a nonsteroidal anti-inflammatory drug product, yet the recent state and local procurement activity indexed under this code does not align with diclofenac procurement. The single tracked opportunity—Seminole County, Florida's IFB for naloxone and drug deactivation systems—represents a categorization mismatch rather than authentic diclofenac buying activity. The code shows little relevant recent activity; state and local governments' actual diclofenac purchases, if solicited through public procurement channels, are not currently reflected in the tracked opportunities under this code.

Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, and the contract included a two-year initial term with a one-year renewal option. Bidders were required to submit unit costs, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement was potentially funded through FEMA and subject to federal environmental compliance standards. The code's nominal scope—diclofenac pharmaceutical procurement—remains unvalidated by current state and local activity, suggesting the code may not be a reliable filtering criterion for market participation in this commodity area.

Quick answers

What is UNSPSC 51383304?

UNSPSC 51383304 is Diclofenac, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51383304?

UNSPSC 51383304 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51383304

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code